Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial

The CLARITY trial (Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease) is a two-arm, multi-centre, randomised controlled trial being run in India and Australia that investigates the effectiveness of angiotensin receptor blockers in addition to standard care compa...

Descripción completa

Detalles Bibliográficos
Autores principales: McGree, J. M., Hockham, C., Kotwal, S., Wilcox, A., Bassi, A., Pollock, C., Burrell, L. M., Snelling, T., Jha, V., Jardine, M., Jones, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044378/
https://www.ncbi.nlm.nih.gov/pubmed/35477480
http://dx.doi.org/10.1186/s13063-022-06167-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044378/
https://www.ncbi.nlm.nih.gov/pubmed/35477480
http://dx.doi.org/10.1186/s13063-022-06167-2

Ejemplares similares